Herceptin
I have been researching Herceptin & found there is a C-myc Gene that influences response to Herceptin. An OncoEd reporter- Dr.Charles H.Weaver reported on 12/14/05: Among patients with amplification of both HER2 & C-myc Gene, the addition ot Herceptin to chemotherapy reduced the risk of cancer recurrence by 76& & reduced death by 64%. Among patients with amplification of HER2 alone, the addition of Herceptin to chemo reduced recurrence risk by only 37% & did not reduce the risk of death. Has your oncologist mentioned this gene testing? Sheryl
|